Skip to main content
Fig. 2 | Journal of Experimental & Clinical Cancer Research

Fig. 2

From: Linc00152 promotes proliferation in gastric cancer through the EGFR-dependent pathway

Fig. 2

Decreased level of Linc00152 suppressed cell proliferation in vitro. a Expression level of Linc00152 in MGC803 and HGC-27 cells treated with shRNA. b The CCK8 assay detected in different time points including 0, 24, 48 and 72 h showed a decreased level of Linc00152 inhibited the growth of cell lines. Absorbance at 450 nm was presented as the mean ± SEM. c The EDU assay confirmed the functional role of Linc00152 in cell proliferation. The integral optical density value of cells treated with control plasmids was normalized to 100 %. All experiments were performed in triplicate and presented as the mean ± SEM. *indicates P < 0.05 while **indicated P < 0.01

Back to article page